search Result

India's solar equipment sector set for Rs 1 trillion investment: CareEdge

To protect and empower domestic manufacturers, the Indian government has implemented a Basic Customs Duty of 25% on solar cells and 40% on modules imported from China since April 2022. Read more

Lithium-ion battery storage: India’s import dependency to fall to 20% by FY27

The GoI has taken initiatives on several demand-side measures, such as Faster Adoption and Manufacturing of Electric Vehicles (FAME) scheme, Viability Gap Funding (VGF) scheme for Battery Energy Storage System (BESS), helping to bring down cost of EV and BESS, thereby stimulating demand. Read more

The Rise of India’s Construction Equipment Industry

Driven by increased government spending, rapid urbanization, technological advancements, and the 'Make in India' initiative, the RAHSTA (road) ahead for the construction equipment (CE) industry is bright with full of possibilities and opportunitiesRead more

RAHSTA Expo 2024 concludes to a grand success

Smart Manufacturing & Enterprises (SME) and Equipment India (EI) host construction equipment (CE) industry leaders to discuss the future of CE industry. The 10th India Construction Festival (ICF) 2024 awards over 75 companies from infrastructure industry. Read more

Alang-Gujarat’s ship recycling industry eyes 10% CAGR by CY28

As newer, more efficient vessels are introduced, older ships become increasingly unviable for operation.Read more

Budget 2024-25: Analysis of Budget impact on MSMEs

The budget places special attention on MSMEs and labour-intensive manufacturing, introducing a new assessment model for MSME credit by public sector banks based on digital footprints rather than only on assets and turnover criteria. Read more

Commercial vehicles to decline 3-6%; two-wheelers to grow 7-9% in FY25 India

Both segments have experienced significant transformations and faced unique challenges over the past few years, particularly in the wake of the COVID-19 pandemic.Read more

Indian pharmaceutical industry to expand by 9%; surpass $70 billion by FY27

Between FY13 and FY18, Indian pharma companies faced severe regulatory challenges that adversely impacted their operations and ability to launch new products in regulated markets. Read more

Increased scrutiny by US FDA: A boon or bane Indian pharmaceutical sector

Even with the surge in USFDA-approved manufacturing sites in India, the proportion of Official Action Initiated (OAI) observations by the USFDA has stayed consistent at 10% of total inspections in CY23. Read more

PV sale volumes to grow 3%-5% in FY25; CareEdge

The industry is expected to exhibit moderate volume growth on account of a high base effect of FY24, shrinking order book and expectation of persistently subdued demand for entry-level variants in FY25. Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016